These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 25733675)

  • 1. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
    Wang Y; Berlin JA; Pinheiro J; Wilcox MA
    Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bounds on potential risks and causal risk differences under assumptions about confounding parameters.
    Chiba Y; Sato T; Greenland S
    Stat Med; 2007 Dec; 26(28):5125-35. PubMed ID: 17525935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Principal stratification with predictors of compliance for randomized trials with 2 active treatments.
    Roy J; Hogan JW; Marcus BH
    Biostatistics; 2008 Apr; 9(2):277-89. PubMed ID: 17681993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity analysis of intention-to-treat estimates when withdrawals are related to unobserved compliance status.
    Salim A; Mackinnon A; Griffiths K
    Stat Med; 2008 Apr; 27(8):1164-79. PubMed ID: 17724782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A causal proportional hazards estimator for the effect of treatment actually received in a randomized trial with all-or-nothing compliance.
    Loeys T; Goetghebeur E
    Biometrics; 2003 Mar; 59(1):100-5. PubMed ID: 12762446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity analysis for principal ignorability violation in estimating complier and noncomplier average causal effects.
    Nguyen TQ; Stuart EA; Scharfstein DO; Ogburn EL
    Stat Med; 2024 Aug; 43(19):3664-3688. PubMed ID: 38890728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Likelihood methods for treatment noncompliance and subsequent nonresponse in randomized trials.
    O'Malley AJ; Normand SL
    Biometrics; 2005 Jun; 61(2):325-34. PubMed ID: 16011678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of acyclovir on herpetic ocular recurrence using a structural nested model.
    Cole SR; Chu H
    Contemp Clin Trials; 2005 Jun; 26(3):300-10. PubMed ID: 15911464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical power in randomized intervention studies with noncompliance.
    Jo B
    Psychol Methods; 2002 Jun; 7(2):178-93. PubMed ID: 12090409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of non-compliance on intent-to-treat analysis of equivalence trials.
    Sheng D; Kim MY
    Stat Med; 2006 Apr; 25(7):1183-99. PubMed ID: 16220491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causal proportional hazards models and time-constant exposure in randomized clinical trials.
    Loeys T; Goetghebeur E; Vandebosch A
    Lifetime Data Anal; 2005 Dec; 11(4):435-49. PubMed ID: 16328570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bias in estimating the causal hazard ratio when using two-stage instrumental variable methods.
    Wan F; Small D; Bekelman JE; Mitra N
    Stat Med; 2015 Jun; 34(14):2235-65. PubMed ID: 25800789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches.
    Little RJ; Rubin DB
    Annu Rev Public Health; 2000; 21():121-45. PubMed ID: 10884949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical considerations in the intent-to-treat principle.
    Lachin JM
    Control Clin Trials; 2000 Jun; 21(3):167-89. PubMed ID: 10822117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The compliance score as a regressor in randomized trials.
    Joffe MM; Ten Have TR; Brensinger C
    Biostatistics; 2003 Jul; 4(3):327-40. PubMed ID: 12925501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive design: estimation and inference with censored data in a semiparametric model.
    Shen Y; Cheng Y
    Biostatistics; 2007 Apr; 8(2):306-22. PubMed ID: 16787996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sensitivity analysis approach for the causal hazard ratio in randomized and observational studies.
    Axelrod R; Nevo D
    Biometrics; 2023 Sep; 79(3):2743-2756. PubMed ID: 36385393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Mayo Lung Cohort: a regression analysis focusing on lung cancer incidence and mortality.
    Strauss GM
    J Clin Oncol; 2002 Apr; 20(8):1973-83. PubMed ID: 11956255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model misspecification sensitivity analysis in estimating causal effects of interventions with non-compliance.
    Jo B
    Stat Med; 2002 Nov; 21(21):3161-81. PubMed ID: 12375297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causal inference from randomized trials in social epidemiology.
    Kaufman JS; Kaufman S; Poole C
    Soc Sci Med; 2003 Dec; 57(12):2397-409. PubMed ID: 14572846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.